Has over 15 years' experience in research, strategy, portfolio management, BD and Alliances and commercialization in top MNC pharmaceuticals in US, EU and China marketing, with a focus on Ophthalmology, Neuroscience, Hematology and Immunology. Successfully led the commercialization of Eylea and Lucentis in China. Currently works at Neurophth taking charge of BD, Alliances and global commercialization readiness.